Open Orphan: Flu vaccine data showcased in peer reviewed article – Proactive Investors
by Ian Lyall. FLU-v has been developed by Imutex, 49%-owned by Open Orphan unit hVIVO The results of a successful phase IIb trial of a potential flu vaccine being developed by an Open Orphan PLC (LON:ORPH) joint-venture have been written up in a peer-reviewed article carried by a scientific journal. The data from FLU-v 004 […]
Cadence Minerals chief provides upbeat assessment of Brazil iron ore project as green light is given for stockpile exports – Proactive Investors
by Ian Lyall. Speaking to Proactive’s Andrew Scott earlier, Kiran Morzaria said the former Anglo American and Cliffs Natural Resources mine, which is in the north of the country, had been “substantially de-risked” Cadence Minerals PLC (LON:CNC) chief executive, Kiran Morzaria, provided an upbeat assessment of the potential of the Amapá iron ore project in […]
Mail Online: Small Cap Movers – A good week for Tertiary Minerals #TYM
by Ian Lyall – Proactive Investors for This Is Money Sticking with the risers for a little while longer: it was a good week for AIM-listed Tertiary Minerals #TYM which doubled in value on Friday. This came after the German group Possehl said it would help the junior miner develop its three main projects. Tertiary is London’s […]
Feedback chairman says cancer software has ‘real potential’ – Proactive Investors
By Ian Lyall – Proactive Investors Distilled down to the basics, the company’s TexRAD technology is essentially a very smart piece of software that analyses medical images, to reveal features that are not always evident to the human eye. Dr Alastair Riddell’s CV reveals a high-flying career with the forerunners of what are now GE […]